Pericardial effusion endangering cardiac tamponade in cases of patients suffering for malignant diseases – diagnostics and management
Journal Title: OncoReview - Year 2012, Vol 2, Issue 1
Abstract
Pericardial effusion endangering cardiac tamponade is a condition of high risk of life loss. In case of endangering cardiac tamponade the most important are: fast diagnosis, pericardiocentesis and drainage of the pericardial cavity. Etiology of cardiac tamponade is the same in cases of patients suffering for malignant disease and others patients – one and only difference is the proportion of etiological factors. The most problematical in clinical management are usually cases of pericarditis caused by neoplastic cells – most often in course of non-microcellular pulmonary carcinoma, mediastinal lymphomas, leukemias, esophageal cancer, breast cancer, malignant mesotheliomas, metastatic ovarian, prostate cancer or melanoma. Clinical course and increasing of symptoms are directly dependent on grade of heart’s hemodynamic incompetence caused by decrease of blood’s inflow into the heart’s cavities. Symptoms are also dependent on time during the liquid increase its’ value inside the pericardial cavity. Some patients usually don’t present the classic Beck’s triad of symptoms. Almost every single patient who is endangered cardiac tamponade presents other symptoms like: decrease of physical efficiency, static dyspnea, tachycardia and pulsus paradoxalis. Key role in diagnostics and assignment of indication for invasive intervention belongs to transthoracic echocardiography. Main and the most important procedures in most of cases of cardiac tamponade are pericardiocentesis and drainage of pericardial cavity. Evacuated liquid is a very valuable diagnostic material which can be helpful in final diagnosis’ establishment. Systemic causal treatment sometimes is added by intrapericardial infusions – in cases of neoplastic pericarditis there is a place of palliative intrapericardial administration of chemotherapeutics. Patients after the pericardiocentesis procedure should be admitted to Intensive Care Unit or Department and carefully observed.
Authors and Affiliations
Artur Matyszewski, Ksenia Krawentek-Matyszewska
Keywords
Related Articles
- EP ID EP53141
- DOI -
- Views 212
- Downloads 0
Retrospective assessment of everolimus treatment in patients suffering from advanced renal cell carcinoma
Objective: Results of second-line everolimus treatment in clear cell renal carcinoma. Material and methods: Clinical data of 32 patients of the Clinic of Systemic and Metastatic Malignancies, Centre of Oncology, Maria...
Pazopanib - dilemmas in kidney cancer treatment
Progress in metastatic renal cell carcinoma treatment is generally based on new registered drugs. This brings improvement of results but it also needs the choice of proper drug. The decision is especially important in in...
Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients With Metastatic Neuroendocrine Midgut Tumors: A Report From the PROMID Study Group
Purpose: Somatostatin analogs are indicated for symptom control in patients with gastroenteropancreatic neuroendocrine tumors (NETs). The ability of somatostatin analogs to control the growth of well-differentiated metas...
Ongoing research developments in cardio-oncology
Administration of liposomal doxorubicin in patients with metastatic breast cancer and significant concomitant cardiovascular conditions
A frequent dilemma faced by an oncologist about to take decision on a chemotherapeutic regime for patients with metastatic breast cancer is how to maintain balance between the expected treatment efficacy and predictable...